News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for July 2025 Caitlin E. Cox July 31, 2025
News Conference News European Congress on Obesity 2025 SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly Michael O'Riordan May 14, 2025
News Daily News Newer Weight-Loss Drugs Not Cost-effective at Current Prices Michael O'Riordan March 18, 2025
News Daily News CVD Hospitalization in Older Adults Higher in US Than in Denmark Michael O'Riordan February 07, 2025
News Daily News Cardiometabolic Trends Dominate First Round of Drugs Chosen for Medicare Price Negotiations L.A. McKeown January 31, 2025
News Daily News Could Pricey GLP-1 Drugs Cut Healthcare Costs? The Math Isn’t Simple L.A. McKeown December 09, 2024
News Daily News CMS Proposal Would Expand Medicare, Medicaid Coverage for GLP-1 Drugs Todd Neale November 27, 2024
News Daily News Studies Highlight Rapid Growth of Semaglutide Use, Risks of Some Online Sources Todd Neale August 12, 2024
News Daily News No Uptick in Suicidal Thinking With GLP-1 Drugs: Medicare Data Yael L. Maxwell July 15, 2024
News Daily News As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness L.A. McKeown June 05, 2024
News Conference News AHA 2023 Full SELECT Results Affirm CV Risk Reduction With Semaglutide in Nondiabetics Todd Neale November 11, 2023
News Daily News SELECT: Semaglutide Cuts CV Events in Adults With Overweight or Obesity Todd Neale August 08, 2023
News Daily News Semaglutide Effective for Weight Loss in Adolescents: STEP TEENS Michael O'Riordan December 30, 2022
News Conference News SCCT 2019 Imaging, Genes, Wearables: Some Predictions for the Future of Preventive Cardiology Yael L. Maxwell July 15, 2019
News Daily News Patients Stop CVD Medications When Their Pharmacy Closes Michael O'Riordan April 19, 2019